Triptorelin/GnRH 2mg/vial Treatment Of Hormone-dependent Diseases

Triptorelin/GnRH 2mg/vial Treatment Of Hormone-dependent Diseases
Product Introduction:
Triptorelin (a GnRH agonist) offers the core benefit of precisely and reversibly regulating sex hormone levels for the treatment of hormone-dependent diseases . Initial use provides a brief flare effect, followed by sustained downregulation of pituitary receptors, strongly inhibiting gonadotropin secretion and significantly reducing testosterone or estrogen levels. This makes it effective in treating advanced prostate cancer, endometriosis, uterine fibroids, precocious puberty, and other conditions. In assisted reproductive technology, it can be used for pituitary downregulation. Its potent and reversible effects (function recovers after discontinuation) provide a crucial treatment option for various gynecological, urogenital tumors, and endocrine disorders.
Send Inquiry
Description
Technical Parameters

Triptorelin 2mg/bottle core introduction

Gonadotropin-releasing hormone analogues | Long-acting GnRH agonists 2mg/vial

Generic name : Triptorelin

English name : Triptorelin

Sequence : pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2

Molecular weight : Approximately 1311.5 Da

Purity : ≥98.0% (HPLC)

Content : 2mg/bottle

Appearance : White lyophilized powder

Storage : Freeze at -20℃, protect from light, and store in a dry place.


Usage and Storage Guide

Triptorelin:

Triptorelin is a synthetic analog of natural gonadotropin-releasing hormone (GnRH). By replacing the glycine at position 6 with D-tryptophan, it significantly enhances the binding affinity to GnRH receptors and the resistance to enzymatic degradation. Unlike the pulsatile secretion characteristics of natural GnRH, triptorelin produces a potent receptor desensitization effect upon continuous administration, ultimately leading to profound suppression of pituitary gonadotropin secretion. Its unique "ignition-inhibition" dual effect makes it irreplaceable in studying the regulatory mechanisms of the hypothalamus-pituitary-gonadal axis, treatment strategies for hormone-dependent diseases, and reproductive endocrinology-related research.

Due to its potent and sustained pituitary suppression, triptorelin is a preferred choice for researchers in endocrinology, oncology, and reproductive medicine. Compared to natural GnRH, which requires pulsatile administration, its long-acting, sustained-release properties offer operational advantages in studying sustained sex hormone suppression and assessing the inhibitory effects on hormone-dependent tumor growth. Its well-defined dose-dependent effect makes it a standardized and predictable key tool in preclinical models of diseases such as prostate cancer, breast cancer, endometriosis, and central precocious puberty.

Triptorelin Applications:

In the initial stage, it briefly stimulates the pituitary gland to release gonadotropins, which then produce a potent pituitary desensitization effect through receptor downregulation, leading to a sustained and profound suppression of sex hormone secretion. Triptorelin is a potent GnRH agonist based on a "fire-inhibition" biphasic action and is a classic tool for studying the inhibition of sex hormone axis function.

Triptorelin is widely used in hormone-dependent tumor models, reproductive endocrinology studies, and the exploration of precocious puberty mechanisms. Its well-defined pharmacological mechanism of action provides a high-quality research model for evaluating novel hormone therapy regimens, studying the long-term response of the pituitary gland to GnRH analogues, and exploring the role of sex hormones in disease development. It is also crucial in evaluating antitumor drugs and studying the physiological effects of gonadal suppression.


Usage and Storage Methods

1. Reconstitution and preparation :

Recommended solvent :

Preferred solvent : sterile water for injection or sterile sodium acetate buffer solution with pH 5.0-7.0.

Stability optimization : Sterile water for injection containing 0.1% mannitol

For internal injection : dilute with sterile saline.

Important note : Avoid using alkaline solvents or solvents containing preservatives (such as benzyl alcohol).

Standard preparation procedure :

Solvent preparation :

Solvents were sterile filtered through a 0.22 μm filter membrane.

The solvent temperature was restored to room temperature (20-25℃).

Reconstitution procedure :

Add 1.0 mL of the recommended solvent to a 2 mg vial.

Slowly pour the powder along the bottle wall to avoid direct impact on the powder.

Gently rotate the vial for 3-5 minutes until completely dissolved.

Final concentration: 2 mg/mL (approximately 1.52 mM)

Dispensing and dilution :

Immediately dispense into single-use doses of 20-50 μL using low-adsorption cryovials.

Dilute to the required working concentration with sterile saline or PBS.

Clear labeling: Name, concentration, preparation date, batch number

Strictly avoid light during operation.

Working concentration/dosage reference :

In vitro cell experiments : Commonly used concentration range is 0.1 nM to 1 μM

Animal in vivo experiments : The commonly used dosage range is 50 to 500 μg/kg (subcutaneous injection, single dose or as per the study protocol).

Example of preparation calculation : If a 1 μM working solution is required, take 0.66 μL of stock solution and add it to 1 mL of culture medium.

Key points to note :

Dissolve gently : Avoid swirling or violent shaking; gently rotate to dissolve.

Strict aseptic technique : Operations are performed within a laminar flow hood, using sterile consumables.

Complete protection from light : Sensitive to light, all steps must be performed under light-protected conditions.

Prepare and use immediately : Stability is limited after reconstitution, so it is recommended to use as soon as possible.

To avoid adsorption : Dilute with a solution containing 0.1% bovine serum albumin or silanized low-adsorption tubes.

2. Storage conditions :

Unreconstituted lyophilized powder :

Long-term storage : Frozen at -20℃, shelf life 24 months

Optimal storage : -80°C (deep freeze), shelf life 36 months.

Strictly protected from light : Must be stored in the original light-proof aluminum foil bag.

Moisture protection : Keep dry, with built-in desiccant.

Reconstituted solution :

immediately after reconstitution for optimal activity.

Short-term storage : Refrigerate at 2-8℃, away from light, for no more than 8 hours.

Repackage and freeze : Store at -20℃ or -80℃ away from light, for no more than 1 week.

Repeated freeze-thaw cycles are strictly prohibited : a maximum of one freeze-thaw cycle.

Transportation conditions :

Freeze-dried powder : transported with dry ice (-78℃)

Short-term shipping : Transported with ice packs at 2-8℃, ensuring delivery within 48 hours.

Packaging : Light-proof aluminum foil bag + vacuum seal + foam insulated box

3. Stability and Processing Standards :

Chemical and physical stability :

It is relatively stable in aqueous solutions with a pH range of 5.0–7.0.

Avoid contact with strong acids, strong alkalis, and oxidizing agents.

Sensitive to mechanical stress (such as violent blowing or vortexing).

Maintenance of bioactivity :

Proper aliquoting and storage at -80°C are key to maintaining long-term activity.

Thaw and dispense the solution slowly on ice before use.

 

Need anything, please contact us

WhatsApp

+852 4671 8216

Telegram

Allenraws

Email

Allenraws810@gmail.com

product-1268-769

 

Hot Tags: triptorelin/gnrh 2mg/vial treatment of hormone-dependent diseases, China triptorelin/gnrh 2mg/vial treatment of hormone-dependent diseases manufacturers, suppliers, factory, AOD9604 Ideal For Competition Prep Peak Weeks, ace 031 1mg, buy aod 9604 pills, peptide cjc ipamorelin, Alternative to GHRP 6, hgh ipamorelin

Send Inquiry
contact us